OpGen (OPGN) Competitors $0.04 0.00 (0.00%) As of 08/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock OPGN vs. BACK, BTTX, UPHL, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, and PIIIWShould you be buying OpGen stock or one of its competitors? The main competitors of OpGen include IMAC (BACK), Better Therapeutics (BTTX), UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), and P3 Health Partners (PIIIW). These companies are all part of the "healthcare" industry. OpGen vs. Its Competitors IMAC Better Therapeutics UpHealth Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners IMAC (NASDAQ:BACK) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment. Is BACK or OPGN more profitable? IMAC has a net margin of 0.00% compared to OpGen's net margin of -1,140.36%. Company Net Margins Return on Equity Return on Assets IMACN/A N/A -325.44% OpGen -1,140.36%N/A -287.58% Do insiders & institutionals hold more shares of BACK or OPGN? 5.8% of IMAC shares are owned by institutional investors. Comparatively, 2.7% of OpGen shares are owned by institutional investors. 12.3% of IMAC shares are owned by insiders. Comparatively, 43.8% of OpGen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, BACK or OPGN? IMAC has a beta of 2.19, suggesting that its stock price is 119% more volatile than the S&P 500. Comparatively, OpGen has a beta of -1.66, suggesting that its stock price is 266% less volatile than the S&P 500. Which has better valuation and earnings, BACK or OPGN? IMAC has higher earnings, but lower revenue than OpGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIMAC$72.05K2.01-$9.42MN/AN/AOpGen$2.67M0.15-$32.67MN/AN/A Does the media refer more to BACK or OPGN? In the previous week, OpGen's average media sentiment score of 1.00 beat IMAC's score of 0.00 indicating that OpGen is being referred to more favorably in the news media. Company Overall Sentiment IMAC Neutral OpGen Positive SummaryIMAC beats OpGen on 5 of the 9 factors compared between the two stocks. Get OpGen News Delivered to You Automatically Sign up to receive the latest news and ratings for OPGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPGN vs. The Competition Export to ExcelMetricOpGenMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$396K$812K$5.59B$9.53BDividend YieldN/AN/A4.73%4.14%P/E RatioN/AN/A28.9123.88Price / Sales0.150.99448.7998.82Price / CashN/AN/A35.6858.35Price / Book0.000.118.165.60Net Income-$32.67M-$27.68M$3.25B$265.26M7 Day PerformanceN/AN/A1.15%-0.14%1 Month PerformanceN/AN/A8.25%6.08%1 Year PerformanceN/AN/A29.18%24.22% OpGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPGNOpGenN/A$0.04flatN/A-98.5%$396K$2.67M0.00100BACKIMACN/A$0.06flatN/A-96.0%$124K$72.05K0.00180Gap UpBTTXBetter TherapeuticsN/A$0.00flatN/A+0.0%$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-99.9%$4K$130M0.001,750ACONWAclarionN/A$0.03-1.0%N/A-32.6%$0.00$54.60K0.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$10.25-1.9%N/A+210.9%$0.00$1.34B0.001,520News CoverageGap DownDHACWDigital Health AcquisitionN/A$0.06-5.8%N/A-70.6%$0.00N/A0.00N/AGap UpFMSFresenius Medical Care AG & Co. KGaA3.7138 of 5 stars$26.07+0.9%$27.80+6.6%+29.9%$0.00$20.63B23.271,384News CoveragePositive NewsGap UpLFMDPLifeMDN/A$24.23+0.9%N/A+12.7%$0.00$234.01M0.00230Positive NewsOTRKPOntrakN/A$0.25-7.4%N/A-89.9%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01-1.9%N/A-75.2%$0.00$1.49B0.00500Positive NewsHigh Trading Volume Related Companies and Tools Related Companies BACK Competitors BTTX Competitors UPHL Competitors ACONW Competitors AONC Competitors DHACW Competitors FMS Competitors LFMDP Competitors OTRKP Competitors PIIIW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OPGN) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OpGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OpGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPGN Stock Alerts